China evaluates the need for scientific failure

Chinese officials are mulling a new law that will officially sanction the value of scientific failure. A draft amendment to the Law on Science and Technology Process would clarify that scientists undertaking high-risk projects would not have to be concerned about the loss of future funding in light of a failed experiment. The top minister for science has been worried that scientists feel a considerable amount of pressure to report successes--particularly in the field of drug research. That's causing some researchers to steer away from the toughest projects--to say nothing about increasing the likelihood of fraudulent results. In drug research, of course, failure is a familiar feature in the field. And without regular failures, no one expects rapid progress.

- read the report on the proposed law from DrugResearcher.com

Related Articles:
China pushes drug development as R&D soars. Report
China now leads India in ongoing clinical trials. Report
Disgraced scientist back at work on cloned embryos. Report

Suggested Articles

Treating mice with niacin increased the number of immune cells in glioblastomas, reducing tumor size and extending survival.

Efforts to pivot existing discoveries into COVID-19 cures may not bear fruit until the pandemic has ended but could help fend off future outbreaks.

GigaGen joined a group of companies making plasma-based, polyclonal antibody treatments for COVID-19.